[HTML][HTML] Th17 CD4+ T-cell as a preferential target for HIV reservoirs

C Renault, N Veyrenche, F Mennechet… - Frontiers in …, 2022 - frontiersin.org
Among CD4+ T-cells, T helper 17 (Th17) cells play a sentinel role in the defense against
bacterial/fungal pathogens at mucosal barriers. However, Th17 cells are also highly susceptible …

Monocyte CD169 expression as a biomarker in the early diagnosis of coronavirus disease 2019

…, D Morquin, P Bourgoin, N Veyrenche… - The Journal of …, 2021 - academic.oup.com
We assessed the expression of CD169, a type I interferon-inducible receptor, on monocytes
(monocyte CD169 [mCD169]) in 53 adult patients admitted to the hospital during the …

Diagnosis value of SARS‐CoV‐2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission

N Veyrenche, K Bolloré, A Pisoni… - Journal of medical …, 2021 - Wiley Online Library
The implementation of rapid diagnostic tests (RDTs) may enhance the efficiency of severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) testing, as RDTs are widely …

Severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in urine of hospitalized patients with coronavirus disease 2019

N Veyrenche, A Pisoni, S Debiesse… - The Journal of …, 2022 - academic.oup.com
… for both N-IgA and N-IgG in urine (data not shown). Signal ratios for N-IgA and N-IgG were
… threshold as for plasma, N-IgA was detected in 17 of 82 patients (20.7%), and N-IgG in 6 of …

Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift β-Thalassemia Mutation [HBB: c …

…, I Déme Ly, C Renoux, L Chillotti, N Veyrenche… - …, 2017 - Taylor & Francis
Sickle cell disease is a genetic disorder with a large variability in the pattern and severity of
clinical manifestations. Different genetic modulators have been identified but very few …

[HTML][HTML] Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents

…, A Pisoni, N Veyrenche, S Rafasse, C Niel, N Gros… - Scientific Reports, 2022 - nature.com
… levels against N-protein 6 weeks after a second BNT162b2 dose in residents infected in
the previous 9–12 months vs. the previous 3–7 months, and we evaluated the impact of N-IgG …

SARS-CoV-2 nucleocapsid antigen in urine of hospitalized patients with Covid-19

N Veyrenche, A Pisoni, S Debiesse, K Bollore… - medRxiv, 2021 - medrxiv.org
Introduction SARS-CoV-2 nucleocapsid antigen (N-Ag) can be detected in the blood of
patients with Covid-19. In this study, we used a highly sensitive and specific nucleocapsid-Ag …

SARS-CoV-2 nucleocapsid urine antigen in hospitalized patients with Covid-19

N Veyrenche, A Pisoni, S Debiesse… - The Journal of …, 2022 - ncbi.nlm.nih.gov
… We studied urine and blood N-Ag using highly sensitive … N-Ag is present in the urine of
patients hospitalized in the early phase of Covid-19. As a direct marker of SARS-CoV-2, urinary N-…

Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019

…, D Morquin, P Bourgoin, N Veyrenche… - The Journal of …, 2022 - academic.oup.com
… Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, Frank Mennechet, Fabrice
Malergue, Amandine Pisoni, Esperance Nyiramigisha, Lise Montagnier, Karine Bollore, Ségolène …

Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission (preprint)

N Veyrenche, K Bollore, A Pisoni, AS Bedin… - 2020 - pesquisa.bvsalud.org
ObjectivesThe implementation of rapid diagnostic tests (RDTs) may enhance the efficiency of
SARS-CoV-2 testing, as RDTs are widely accessible and easy to use. The aim of this study …